vs
GEE Group Inc.(JOB)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
GEE Group Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.0倍($20.5M vs $19.6M),GEE Group Inc.净利率更高(-0.7% vs -177.4%,领先176.7%),STANDARD BIOTOOLS INC.同比增速更快(-11.5% vs -21.2%),GEE Group Inc.自由现金流更多($-1.2M vs $-23.1M),过去两年GEE Group Inc.的营收复合增速更高(-10.5% vs -12.2%)
GEE Group Inc.是总部位于美国的专业人力资源解决方案提供商,提供临时用工、合同工安置及永久岗位招聘服务,覆盖信息技术、医疗、财会、法律、轻工制造等核心领域,服务北美市场各规模的客户。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
JOB vs LAB — 直观对比
营收规模更大
JOB
是对方的1.0倍
$19.6M
营收增速更快
LAB
高出9.7%
-21.2%
净利率更高
JOB
高出176.7%
-177.4%
自由现金流更多
JOB
多$21.9M
$-23.1M
两年增速更快
JOB
近两年复合增速
-12.2%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $20.5M | $19.6M |
| 净利润 | $-150.0K | $-34.7M |
| 毛利率 | 36.1% | 48.5% |
| 营业利润率 | -2.0% | -168.5% |
| 净利率 | -0.7% | -177.4% |
| 营收同比 | -21.2% | -11.5% |
| 净利润同比 | 78.3% | -28.8% |
| 每股收益(稀释后) | $0.00 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
JOB
LAB
| Q4 25 | $20.5M | — | ||
| Q3 25 | $23.5M | $19.6M | ||
| Q2 25 | $24.5M | $21.8M | ||
| Q1 25 | $24.5M | $40.8M | ||
| Q4 24 | $24.0M | — | ||
| Q3 24 | $23.7M | $22.1M | ||
| Q2 24 | $27.0M | $22.5M | ||
| Q1 24 | $25.6M | $45.5M |
净利润
JOB
LAB
| Q4 25 | $-150.0K | — | ||
| Q3 25 | $-513.0K | $-34.7M | ||
| Q2 25 | $-423.0K | $-33.5M | ||
| Q1 25 | $-33.1M | $-26.0M | ||
| Q4 24 | $-692.0K | — | ||
| Q3 24 | $-2.3M | $-26.9M | ||
| Q2 24 | $-19.3M | $-45.7M | ||
| Q1 24 | $-1.0M | $-32.2M |
毛利率
JOB
LAB
| Q4 25 | 36.1% | — | ||
| Q3 25 | 35.8% | 48.5% | ||
| Q2 25 | 35.4% | 48.8% | ||
| Q1 25 | 34.1% | 48.4% | ||
| Q4 24 | 33.0% | — | ||
| Q3 24 | 37.1% | 54.9% | ||
| Q2 24 | 34.1% | 46.1% | ||
| Q1 24 | 32.8% | 53.1% |
营业利润率
JOB
LAB
| Q4 25 | -2.0% | — | ||
| Q3 25 | -3.3% | -168.5% | ||
| Q2 25 | -2.2% | -118.1% | ||
| Q1 25 | -94.8% | -80.8% | ||
| Q4 24 | -3.2% | — | ||
| Q3 24 | -5.8% | -120.9% | ||
| Q2 24 | -76.6% | -134.5% | ||
| Q1 24 | -7.6% | -132.2% |
净利率
JOB
LAB
| Q4 25 | -0.7% | — | ||
| Q3 25 | -2.2% | -177.4% | ||
| Q2 25 | -1.7% | -153.7% | ||
| Q1 25 | -135.2% | -63.8% | ||
| Q4 24 | -2.9% | — | ||
| Q3 24 | -9.5% | -122.0% | ||
| Q2 24 | -71.3% | -203.3% | ||
| Q1 24 | -3.9% | -70.6% |
每股收益(稀释后)
JOB
LAB
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.01 | $-0.09 | ||
| Q2 25 | $0.00 | $-0.09 | ||
| Q1 25 | $-0.30 | $-0.07 | ||
| Q4 24 | $-0.01 | — | ||
| Q3 24 | $-0.02 | $-0.07 | ||
| Q2 24 | $-0.18 | $-0.12 | ||
| Q1 24 | $-0.01 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $50.0M | $399.7M |
| 总资产 | $58.9M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
JOB
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务
JOB
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益
JOB
LAB
| Q4 25 | $50.0M | — | ||
| Q3 25 | $50.0M | $399.7M | ||
| Q2 25 | $50.4M | $424.5M | ||
| Q1 25 | $50.6M | $454.6M | ||
| Q4 24 | $83.6M | — | ||
| Q3 24 | $84.2M | $489.3M | ||
| Q2 24 | $86.3M | $510.3M | ||
| Q1 24 | $105.5M | $577.3M |
总资产
JOB
LAB
| Q4 25 | $58.9M | — | ||
| Q3 25 | $60.0M | $539.6M | ||
| Q2 25 | $60.6M | $557.0M | ||
| Q1 25 | $61.8M | $579.6M | ||
| Q4 24 | $92.8M | — | ||
| Q3 24 | $95.9M | $681.5M | ||
| Q2 24 | $96.9M | $708.7M | ||
| Q1 24 | $117.0M | $777.7M |
负债/权益比
JOB
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.2M | $-23.1M |
| 自由现金流率自由现金流/营收 | -5.8% | -118.1% |
| 资本支出强度资本支出/营收 | 0.0% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
JOB
LAB
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $2.4M | $-22.2M | ||
| Q2 25 | $-743.0K | $-20.7M | ||
| Q1 25 | $-24.0K | $-30.3M | ||
| Q4 24 | $-1.1M | — | ||
| Q3 24 | $1.3M | $-27.9M | ||
| Q2 24 | $-1.5M | $-39.0M | ||
| Q1 24 | $1.3M | $-62.5M |
自由现金流
JOB
LAB
| Q4 25 | $-1.2M | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | $-755.0K | $-22.6M | ||
| Q1 25 | $-27.0K | $-35.3M | ||
| Q4 24 | $-1.1M | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | $-1.6M | $-41.0M | ||
| Q1 24 | $1.3M | $-63.3M |
自由现金流率
JOB
LAB
| Q4 25 | -5.8% | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | -3.1% | -103.6% | ||
| Q1 25 | -0.1% | -86.6% | ||
| Q4 24 | -4.7% | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | -5.8% | -182.2% | ||
| Q1 24 | 5.2% | -138.9% |
资本支出强度
JOB
LAB
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | 0.0% | 8.7% | ||
| Q1 25 | 0.0% | 12.4% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 10.2% | ||
| Q2 24 | 0.1% | 8.6% | ||
| Q1 24 | 0.0% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JOB
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |